Our Grants

CIRM provides funding across five key areas: Infrastructure, Education, Discovery Research, Translational Research, and Clinical Research. By supporting projects at every stage of development, from initial discovery to clinical trials, CIRM drives progress in regenerative medicine and accelerates innovative therapies to patients.

See our complete portfolio of awards below.

View Funded Institutions
View Funded Investigators
Find Clinical Trials

All CIRM Grants

Search Filters »

Institution Researcher name Grant Type Grant Title Award Value
University of California, Berkeley David Schaffer Shared Labs The Berkeley Human Embryonic Stem Cell Shared Research Laboratory $1,673,221
Sanford Burnham Prebys Medical Discovery Institute Dr. Evan Y. Snyder Shared Labs Collaborative Laboratory for Human Embryonic Stem Cell Research at Sanford-Burnham Medical Research Institute $1,805,884
Buck Institute for Age Research Dr. Xianmin Zeng Shared Labs North Bay CIRM Shared Research Laboratory for Stem Cells and Aging $3,478,933
Salk Institute for Biological Studies Dr. Inder M. Verma Shared Labs Shared viral vector facility for genetic manipulation of huamn ES cell $1,844,315
Benjamin D. Yu Dr. Benjamin D. Yu New Faculty II Medical School Loan Repayment Program $28,388
Gladstone Institutes, J. David Dr. Yadong Huang New Faculty II Defining the Isoform-Specific Effects of Apolipoprotein E on the Development of iPS Cells into Functional Neurons in Vitro and in Vivo $2,757,303
University of California, San Francisco Dr. Emmanuelle Passegue New Faculty II Mechanisms Underlying the Responses of Normal and Cancer Stem Cells to Environmental and Therapeutic Insults $2,124,488
University of California, San Francisco Dr. Ophir Klein MD, PhD New Faculty II Laying the groundwork for building a tooth: analysis of dental epithelial stem cells $3,075,251
University of California, Merced Dr. Kara E McCloskey New Faculty II Building Cardiac Tissue from Stem Cells and Natural Matrices $1,656,083
University of California, Irvine Dr Edwin S Monuki New Faculty II Mechanisms in Choroid Plexus Epithelial Development $2,793,395
University of California, Berkeley Dr. Lin He New Faculty II The roles of non-coding RNAs in the self-renewal and differentiation of pluripotent stem cells $1,406,823
University of California, San Francisco Dr. Robert Blelloch Dr. New Faculty II Mechanisms of small RNA regulation in early embryonic development $2,790,695
University of California, Los Angeles Dr. Antoni Ribas MD/PhD New Faculty II Stem Cells for Immune System Regeneration to Fight Cancer $3,072,000
San Diego State University Foundation Dr. Ricardo M. Zayas New Faculty II The molecular basis underlying adult neurogenesis during regeneration and tissue renewal $1,712,225
University of Southern California Dr. Qilong Ying New Faculty II Mechanisms Underlying the Diverse Functions of STAT3 in Embryonic Stem Cell Fate Regulation $2,261,174
Stanford University Dr. Katja Weinacht Preclinical Stage Projects Therapeutic Restoration of Immune Function through iPSC-derived Human Thymic Epithelial Cells $12,999,871
EVADE Therapeutics Sonja Schrepfer Preclinical Stage Projects Hypoimmune Stem Cell–Derived Islets: A Next-Generation Cell Therapy Toward a Functional Cure for Type 1 Diabetes $12,480,000
University of Southern California Charles Murry Preclinical Stage Projects Regenerating the Acutely Infarcted Heart with iPSC-Ventricular Cardiomyocytes. $6,891,118
University of California, Los Angeles Dr. Lili Yang Preclinical Stage Projects Stem Cell-Engineered Off-The-Shelf CAR-NKT Cell Therapy for Multiple Sclerosis $7,499,996
Scribe Therapeutics Brett Staahl Preclinical Stage Projects A First-in-Class CIRSPR-CasX Gene Editing Therapy for Lowering Lp(a) to Prevent Cardiovascular Events $12,714,480
4D Molecular Therapeutics, Inc. Sara Collins Preclinical Stage Projects Gene Therapy for Alpha-1 Anti-Trypsin Deficiency $5,915,073
AcuraStem Incorporated Mr. Samuel V. Alworth MS, MBA Preclinical Stage Projects Late-stage development of AS-241, an UNC13A Targeting Antisense Oligonucleotide treatment for Amyotrophic Lateral Sclerosis, for IND-enabling studies $7,500,000
Cure Rare Disease Dr. Tahseen Mozaffar Preclinical Stage Projects Advancement of a myotropic, liver-detargeting therapy for LGMD2i/R9 $7,292,297
Scribe Therapeutics Brett Staahl Preclinical Stage Projects A first-in-class CRISPR-CasX gene editor silencing APOC3 transcription for the treatment of Severe Hypertriglyceridemia $13,000,000
Savanna Biotherapeutics, Inc. Dr. Sunil Gandhi Ph.D Preclinical Stage Projects Microglia replacement therapy for CSF1R-related Leukoencephalopathy $12,993,456
Cedars-Sinai Medical Center Dr. David Joseph Lefer Preclinical Stage Projects TY1 and Semaglutide to Treat Cardiometabolic HFpEF $10,571,220
University of California, San Diego Dr. Stephanie Cherqui Preclinical Stage Projects CRISPR/Cas9-mediated gene editing of Hematopoietic stem and progenitor cells for Friedreich’s ataxia $7,423,504
Cedars-Sinai Medical Center Dr. Alessandra Ciullo Preclinical Stage Projects Noncoding RNA drug TY2 for arrhythmogenic cardiomyopathy $10,419,929
Navega Therapeutics Ana Maria Moreno Preclinical Stage Projects Development of an AAV Epigenetic Gene Therapy for Intractable Chronic Pain Disorders $9,486,864
Scripps Health Dr. Darryl D. D’Lima Preclinical Stage Projects Stem Cell-Based Cartilage Tissue Regeneration $12,715,000
Stanford University Dr. Bertha Chen Preclinical Stage Projects Autologous iPSC-derived progenitor smooth muscle cells for treatment of urinary incontinence $7,275,596
Loma Linda University Hisham Abdel-Azim CCCE Grant Inland Empire and Desert Region CIRM Community Care Center of Excellence $9,000,000
Fresno Community Hospital and Medical Center Haifaa Abdulhaq CCCE Grant Establishing a CIRM Community Care Center of Excellence in the Central Valley $8,996,101
Lundquist Institute for Biomedical Innovation at Harbor – UCLA Medical Center Lynda Polgreen MD CCCE Grant South Los Angeles Community Center of Excellence for Regenerative Medicine $9,000,000
Stanford University Dr. Michael P Snyder PhD ReMIND – Discovery Stage ReMIND Dissecting cell-specific genetic and molecular drivers of amyotrophic lateral sclerosis for therapeutic insights $12,999,837
Stanford University Sergiu P Pasca ReMIND – Discovery Stage ReMIND Transplantation of human forebrain assembloids as a platform for therapeutic screening in neurodevelopmental disorders $13,999,999
University of California, Los Angeles Daniel Geschwind ReMIND – Discovery Stage ReMIND Advancing Therapeutic Discovery Through Multimodal Analyses of Genetic and Cellular Mechanisms in Neuropsychiatric Disorders $13,957,175
University of California, San Diego Dr. Gene Wei-Ming Yeo ReMIND – Discovery Stage ReMIND Reversing age-dependent neurodegeneration by elimination of RNA pollution $11,946,234
Salk Institute for Biological Studies Christian Metallo ReMIND – Discovery Stage ReMIND Tracing the metabolic basis of neurological disorders $12,995,613
University of California, San Francisco Dr. Arnold Kriegstein ReMIND – Discovery Stage ReMIND Defining the Developmental Origins and Neuronal Regulation of Glioblastoma Stem Cells $13,578,858
University of California, San Diego Jonathan Sebat ReMIND – Discovery Stage ReMIND Modeling the genetic basis of psychopathology in schizophrenia and autism $12,703,708
University of California, San Francisco Mercedes Paredes ReMIND – Discovery Stage ReMIND Multi-gene modulation to rescue CNS-associated microdeletion syndromes $6,253,897
University of California, Los Angeles Aparna Bhaduri ReMIND – Discovery Stage ReMIND Defining Neurovascular Metabolism in Neurodevelopmental and Neuropsychiatric Disorders $10,330,000
University of California, San Francisco Tomasz Nowakowski ReMIND – Discovery Stage ReMIND CIRM Center for Neuropsychiatric Stem Cell Proteomics $13,781,522
Scripps Research Institute Xin Jin ReMIND – Discovery Stage ReMIND Translational epigenomics: dissecting cell type-specific function of neuropsychiatric risk genes in vivo $11,376,314
Scripps Research Institute Stuart A Lipton ReMIND – Discovery Stage ReMIND Multiomic Studies of Idiopathic Intellectual Disability and Autism Spectrum Disorder (ID/ASD) $17,365,387
University of California, San Francisco Alex Pollen ReMIND – Discovery Stage ReMIND Deep phenotyping of human brain organoid models of autism spectrum disorder to unravel disease heterogeneity and develop biomarkers and treatments $12,297,272
Coast to Coast Conferences & Events Calli France Conference – 2026 CIRM Trainee Network Conference CIRM Trainee Networking Conference 2026 $425,961
Coast to Coast Conferences & Events Calli France Conference – 2026 CIRM Trainee Network Conference 2025 CIRM Trainee Networking Conference $381,317
University of Southern California Dr. Francesca Mariani Conference – 2026 CIRM Trainee Network Conference Manage the 2024 CIRM Annual Trainee Network Conference $348,626
1 … 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32